From January 1, 2024 to March 31, 2024, the company has repurchased 5,198,975 shares, representing 0.42% for $400 million. With this, the company has completed the repurchase of 18,663,819 shares, representing 1.5% for $1,475.28 million under the buyback announced on February 25, 2020.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.12 USD | -1.14% | -0.74% | -17.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.11% | 84.59B | |
+38.23% | 705B | |
+32.82% | 583B | |
-3.63% | 364B | |
+20.16% | 332B | |
+5.11% | 291B | |
+16.64% | 238B | |
-4.13% | 210B | |
+10.63% | 209B | |
+8.80% | 169B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Tranche Update on Gilead Sciences, Inc.'s Equity Buyback Plan announced on February 25, 2020.